Last update; 19.06.2009

 

 

Hybrid Imaging: coronary or carotid?

 

Myocardial Perfusion SPECT showing a small inferobasal infarction and a relatively large ischemia of the inferior wall. This patient has a significant narrowing of the right coronary artery and a high risk for a re-infarction of the inferior wall.

 

 

 

MSCT of the right coronary artery showing a significant narrowing of the proximal und midportion (> 50%), therefore defining a high risk situation based on a luminogram. The accuracy of the luminogram for ischemia in stenoses with 50-75% narrowing is about 50%: many stenosis of about 50% do NOT define a high risk condition.

 

 

 

Coronary calcifications, as evidenced in this example within the left anterior descending artery increase the risk for acute myocardial infarction: the more calcium, the higher the risk. However, based on pretest probability, patients may not have coronary calcium but a significant narrowing of the coronary system due to SOFT plaques.

 

 

 

Carotid atherosclerosis, which may be quantified using the total plaque area (TPA, see www.tpainfo.ch) is a very good substitute for the risk of having a coronary stenosis > 50% or having a high risk for myocardial infarction.

   
What's the problem? Hybrid imaging is defined by the combination of perfusion and plaque imaging of the heart. The rationale is to better risk stratify subjects with respect to the presence of a significant lumen narrowing in a subject with a normal Stress SPECT study.

Currently, there exist no guidelines for this type of combination.

Usually, a SPECT study is performed with physicial or pharmacologic testing and a coronary angiography is added using MSCT with contrast and cardiac gating. Therefore, anatomical data on the possible presence of a coronary stenosis and funcional data on the risk that a stenosis causes ischemia, are collected.

This kind of imaging goes along with a radiation burden of 10 mSv (at best if Technetium and scan-and-scan is used) to 40 mSv (at worst, if dual isotope plus restrospective oversampling of the heart with CT is used).

   
Is there an alternative ?

Yes!

Better risk stratification is certainly needed, but not with MSCT! In direct comparison (Arterioscler Thromb Vasc Biol. 2006;26:656-662), carotid imaging was superior to rule out a significant stenosis defined by MSCT 50% or more in 36 men and  8 women with 18 subjects having significant CAD. Further, carotid imaging, especially total plaque area (TPA) has an excellent record for the prediction of myocardial infarction and vascular death (AMI and STROKE) both in men and women. Therefore, using carotid imaging, we obtain a more global view of vascular risk, than what is possible with coronary imaging.  
   
Conclusions In a subject with a normal SPECT study (or a normal exercise stress ECHO) and absence of carotid plaques defined by TPA, the addition of a MSCT  coronary imaging study is absolutely useless because the risk, that this subject will develop a myocardial infarction is minimal. This can be deduced mathematically. If you have a normal SPECT study, your risk for AMI is 7/1000/year. If overmore, your TPA = 0, posttest risk is 3/1000/year.

Beside a certain amount of additional radiation burden when MSCT hybrid imaging is used, we should not forget the additional costs. TPA imaging would cost about 75 Swiss francs, coronary imaging with MSCT about 1500 Swiss francs, contrast media included.

The promotion of MSCT hybrid imaging in clinical practice is at the current point of evidence and knowledge not recommendable.

   
Further information

www.tpainfo.ch

http://scopri.ch/posttestcalculators1.html

http://www.nuk.usz.ch/nuk.aspx